jylamvo

Generic: methotrexate

Labeler: shorla oncology inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name jylamvo
Generic Name methotrexate
Labeler shorla oncology inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

methotrexate 2 mg/mL

Manufacturer
SHORLA ONCOLOGY INC.

Identifiers & Regulatory

Product NDC 81927-204
Product ID 81927-204_3a5966e9-256b-4595-b962-e00d07526623
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA212479
Listing Expiration 2026-12-31
Marketing Start 2023-12-15

Pharmacologic Class

Established (EPC)
folate analog metabolic inhibitor [epc]
Mechanism of Action
folic acid metabolism inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 81927204
Hyphenated Format 81927-204

Supplemental Identifiers

RxCUI
2671456 2671462
UPC
0381927204017
UNII
YL5FZ2Y5U1
NUI
N0000175584 N0000000111

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name jylamvo (source: ndc)
Generic Name methotrexate (source: ndc)
Application Number NDA212479 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS
source: ndc

Packages (1)

81927-204-01 1 BOTTLE, GLASS in 1 CARTON (81927-204-01) / 60 mL in 1 BOTTLE, GLASS

Ingredients (1)

methotrexate (2 mg/mL)

Linked Drug Pages (1)

JYLAMVO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a5966e9-256b-4595-b962-e00d07526623", "openfda": {"nui": ["N0000175584", "N0000000111"], "upc": ["0381927204017"], "unii": ["YL5FZ2Y5U1"], "rxcui": ["2671456", "2671462"], "spl_set_id": ["96e931f5-51ae-4bdf-a441-bb0dd26d4c0e"], "pharm_class_epc": ["Folate Analog Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Folic Acid Metabolism Inhibitors [MoA]"], "manufacturer_name": ["SHORLA ONCOLOGY INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (81927-204-01)  / 60 mL in 1 BOTTLE, GLASS", "package_ndc": "81927-204-01", "marketing_start_date": "20231215"}], "brand_name": "JYLAMVO", "product_id": "81927-204_3a5966e9-256b-4595-b962-e00d07526623", "dosage_form": "SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "81927-204", "generic_name": "Methotrexate", "labeler_name": "SHORLA ONCOLOGY INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "JYLAMVO", "active_ingredients": [{"name": "METHOTREXATE", "strength": "2 mg/mL"}], "application_number": "NDA212479", "marketing_category": "NDA", "marketing_start_date": "20231215", "listing_expiration_date": "20261231"}